101 related articles for article (PubMed ID: 18085619)
1. Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival.
Rosenberg R; Nekarda H; Zimmermann F; Becker K; Lordick F; Hofler H; Molls M; Siewert JR
J Surg Oncol; 2008 Jan; 97(1):8-13. PubMed ID: 18085619
[TBL] [Abstract][Full Text] [Related]
2. [T4 rectal carcinoma. Surgical and multimodal therapy].
Rau B; Hohenberger P; Gellermann J; Hünerbein M; Hildebrandt B; Schneider U; Riess H; Wust P; Schlag PM
Chirurg; 2002 Feb; 73(2):147-53. PubMed ID: 11974478
[TBL] [Abstract][Full Text] [Related]
3. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
[TBL] [Abstract][Full Text] [Related]
4. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience.
Valentini V; Coco C; Rizzo G; Manno A; Crucitti A; Mattana C; Ratto C; Verbo A; Vecchio FM; Barbaro B; Gambacorta MA; Montoro C; Barba MC; Sofo L; Papa V; Menghi R; D'Ugo DM; Doglietto G
Surgery; 2009 May; 145(5):486-94. PubMed ID: 19375606
[TBL] [Abstract][Full Text] [Related]
6. [Preoperative radiochemotherapy of rectal carcinoma. Current status].
Rau B; Wust P; Riess H; Schlag PM
Zentralbl Chir; 2000; 125(4):356-64. PubMed ID: 10829316
[TBL] [Abstract][Full Text] [Related]
7. Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service.
Chessin DB; Enker W; Cohen AM; Paty PB; Weiser MR; Saltz L; Minsky BD; Wong WD; Guillem JG
J Am Coll Surg; 2005 Jun; 200(6):876-82; discussion 882-4. PubMed ID: 15922198
[TBL] [Abstract][Full Text] [Related]
8. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S
Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188
[TBL] [Abstract][Full Text] [Related]
9. Is p53 and heat shock protein 70 expression a useful parameter for preoperative hyperthermoradiation therapy in advanced rectal carcinoma.
Takeuchi K; Nakajima M; Miyazaki T; Ide M; Asao T; Fujita K; Kuwano H
Hepatogastroenterology; 2007 Mar; 54(74):367-72. PubMed ID: 17523276
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
11. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
[TBL] [Abstract][Full Text] [Related]
13. Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma.
Gosens MJ; Klaassen RA; Tan-Go I; Rutten HJ; Martijn H; van den Brule AJ; Nieuwenhuijzen GA; van Krieken JH; Nagtegaal ID
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6617-23. PubMed ID: 18006762
[TBL] [Abstract][Full Text] [Related]
14. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
15. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Saltz LB; Goodman KA; Minsky BD; Wong WD; Weiser MR
Cancer; 2008 Jul; 113(1):57-64. PubMed ID: 18442099
[TBL] [Abstract][Full Text] [Related]
16. Combined-modality therapy with sphincter-preserving total mesorectal excision for locally advanced rectal cancer: patient's age and long-term outcome.
Szynglarewicz B; Matkowski R; Maciejczyk A; Kasprzak P; Forgacz J; Pudelko M
J Gastrointestin Liver Dis; 2008 Mar; 17(1):49-52. PubMed ID: 18392244
[TBL] [Abstract][Full Text] [Related]
17. [Comparative diagnosis of locally advanced rectal carcinoma after preoperative therapy].
Barth C; Rau B; Hünerbein M; Schlag PM
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1404-7. PubMed ID: 9931895
[TBL] [Abstract][Full Text] [Related]
18. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant radiochemotherapy for rectal cancer.
Vini L
Dig Dis; 2007; 25(1):56-66. PubMed ID: 17384509
[TBL] [Abstract][Full Text] [Related]
20. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
